Argan (NYSE:AGX) 주식

Argan

Argan, Inc.

AMEX

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

Some Speculative Stocks Can Pay Off

Small Cap

Markets

LWLG

LXRX

무역 정책을 둘러싼 불확실성, 새로운 경기침체 우려, 지속적인 인플레이션으로 인해 지난주 내내 시장이 불안한 모습을 보인 가운데, 몇몇 소형주들이 큰 폭의 상승세를 기록하며 역경을 이겨냈다. 

지난주 미국 증시 전반적 하락에도 상승한 소형주 3종목...최대 60% 급등

Citi Double Cash® Card

Earnings

News

Penny Stocks

Pre-Market Outlook

Trading Ideas

PXMD

미국의 주식 선물이 금요일 아침 조금 더 상승한 상황에서 투자자들의 주목을 끌 수 있는 몇 가지 주식은 다음과 같다. 씨티그룹, JP모건, 웰스 파고, 아르간, 팍스메디카

씨티그룹, JP모건 그리고 금요일을 맞아 주목해야 할 3가지 주식

Argan Inc

ANGLO ASIAN MNG PLC ORD by Anglo Asian Mining Plc.

Anglo Asian Mining PLC

Silver X Mining Corp

Agile Therapeutics Inc Warrants(13/10/2026)

Argentex Group PLC

Agilyx ASA

Disclosed on May 1, Richard H Deily, Compliance Officer at Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: Deily's decision to sell 1,565 shares of Argan was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000100591/000141588925011647//Archives/edgar/data/100591/000141588925011647/0001415889-25-011647-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $238,380.
The latest market snapshot at Friday morning reveals Argan shares up by 1.39%, trading at $161.0.
<h3>About Argan</h3>
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
<h3>Argan: Delving into Financials</h3>
Revenue Growth: Argan's remarkable performance in 3 months is evident. As of 31 January, 2025, the company achieved an impressive revenue growth rate of 41.28%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 20.48%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Argan's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 2.31.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.01, Argan adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 25.82 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 2.53 is above industry norms, reflecting an elevated valuation for Argan's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 17.51 positions the company as being more valued compared to industry benchmarks.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes Worth Your Attention</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000100591">Check Out The Full List Of Argan's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Compliance Officer Of Argan Makes $238K Sale

Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) ("Argan" or the "Company") today announces that its Board of Directors (the "Board") approved an increase to the Company's existing share repurchase program from $125 million to $150 million and declared a regular quarterly cash dividend in the amount of $0.375 per common share, payable on April 30, 2025 to stockholders of record at the close of business on April 22, 2025.
"Expanding our share repurchase program reflects the Board's confidence in Argan's ability to drive long-term growth and reinforces our commitment to delivering long-term value to shareholders," said David Watson, President and Chief Executive Officer of Argan. "We're also pleased to announce a regular quarterly cash dividend of $0.375 per common share.
"Earlier this week we announced that our subsidiary Gemma Power Systems received a notice to proceed on its previously announced engineering, procurement and construction services contract with Sandow Lakes Energy Company, LLC for a 1.2 GW ultra-efficient natural gas-fired power plant that is expected to begin this summer. We are energized by our record backlog and the strong pipeline of opportunities we are seeing now and in future years. We believe our well-recognized capabilities and track record of success leave us well-positioned as our industry gears up to build the high-quality energy assets needed to address the growing demand for reliable 24/7 power."

Buybacks

Argan Approves An Increase To Company's Existing Share Repurchase Program From $125M To $150M

WIIM

AMRC

GNRC

KRNT

LYTS

NDSN

NVEE

PPSI

ROAD

STRL

TGLS

Shares of machinery, electrical equipment and engineering companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

IESC

PRIM

SGBX

USLM

Shares of construction-related stocks are trading lower as markets react to President Trump's announcement of sweeping tariffs.

As uncertainties surrounding trade policies, fresh recession fears, and persistent inflation kept the markets on tenterhooks throughout the past week, a handful of small-caps defied the odds by posting significant gains. 
These stocks, all part of the Russell 2000 index, have market caps lower than $2 billion and have rallied between 11% and 60% over the past week, while the broader index witnessed a pullback of 2.5%. Let us explore these stocks and the various factors contributing to their resilience.
<h2 class="wp-block-heading">1. Lexicon Pharmaceuticals</h2>
The three-decades-old Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) posted a phenomenal 58% rally last week, after announcing that it was entering into an exclusive licensing agreement with Danish pharma giant, Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>). 
The agreement pertains to Lexicon&#8217;s LX9851, an oral non-incretin development candidate for treating obesity and other metabolic disorders. It provides Novo with exclusive rights to develop, manufacture, and commercialize the drug worldwide.
The deal is set to generate Lexicon up to $1 billion in milestone and royalty payments over the coming years, prompting a quick &#8216;Buy&#8217; rating from Joseph Pantginis of H.C. Wainwright, alongside <a href="https://www.benzinga.com/insights/analyst-ratings/25/03/44542815/what-6-analyst-ratings-have-to-say-about-lexicon-pharmaceuticals">several other analysts</a>. 
See Also: <a href="https://www.benzinga.com/markets/equities/25/03/44554008/wall-street-on-edge-futures-slide-ahead-of-trumps-liberation-day-tariff-shock">Wall Street On Edge: Futures Slide Ahead of Trump&#8217;s &#8216;Liberation Day&#8217; Tariff Shock</a>
<h2 class="wp-block-heading">3. LightWave Logic </h2>
LightWave Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWLG#NASDAQ">LWLG</a>) develops photonic devices and electro-optic polymer materials for fiber-optic communications, all of which play a critical role in semiconductor foundries and AI data centers. 
Last week, the company announced its Process Design Kit (PDK) which is now commercially available after already being implemented at two major foundries. This <a href="https://www.benzinga.com/insights/movers/25/03/44547240/12-information-technology-stocks-moving-in-fridays-after-market-session">led the stock to pop 19% on Friday</a>, ending the week up by 10%. A picks-and-shovels play, the stock is expected to maintain momentum as the AI race heats up.
<h2 class="wp-block-heading">3. Argan Inc</h2>
Argan Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>), a Maryland-based engineering, procurement, and construction company that&#8217;s been around since the early-60s. The stock popped nearly 20% on Friday, ending the week up by 11%, following its <a href="https://www.benzinga.com/25/03/44536628/argan-posts-upbeat-results-joins-kulr-technology-abacus-global-management-w-r-berkley-and-other-big-stocks-moving-higher-on-friday">spectacular fourth-quarter earnings performance</a>.
The company reported $232 million in revenue during the fourth quarter, up 40% year-over-year, and a profit of $31.4 million, or $2.22 per share, up 150% year-over-year, while handily beating analyst estimates.
Argan&#8217;s performance is largely owing to its power industry services business, with revenues growing 65% to $196 million, and contributing to its massive order backlog at $1.4 billion, up 80% from the prior year. The company is riding the demand for natural gas-fired power plants to fuel the endless new AI data centers.
Benzinga's Edge Rankings highlight strong momentum and growth ranking For Argan in the 97th and 85th percentile, respectively. Curious how Lexicon Pharmaceuticals stacks up? <a href="https://www.benzinga.com/quote/AGX">Click here</a> to uncover its growth and momentum scores
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AGX"><img loading="lazy" decoding="async" width="1024" height="178" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31010543/Screenshot-2025-03-31-at-10.35.05-AM-1024x178.png" alt="" class="wp-image-848423" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31010543/Screenshot-2025-03-31-at-10.35.05-AM-1024x178.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31010543/Screenshot-2025-03-31-at-10.35.05-AM-300x52.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31010543/Screenshot-2025-03-31-at-10.35.05-AM-768x134.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/31010543/Screenshot-2025-03-31-at-10.35.05-AM.png 1436w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image via Shutterstock
Read More:
<ul>
<li><a href="https://www.benzinga.com/tech/25/03/44552954/inside-apples-silent-revolution-ai-doctors-nutrition-tech-and-a-new-retail-boss">Inside Apple&#8217;s Silent Revolution—AI Doctors, Nutrition Tech, And A New Retail Boss</a></li>
</ul>

While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%

<h3>Gainers</h3>
<ul>
<li>Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) stock moved upwards by 23.6% to $142.42 during Friday's regular session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock rose 17.96% to $1.51. The market value of their outstanding shares is at $16.6 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) stock rose 16.41% to $0.5. The market value of their outstanding shares is at $16.2 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) stock increased by 12.78% to $3.0. The company's market cap stands at $39.0 million. </li>
<li>Sky Harbour Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#NYSE">SKYH</a>) stock moved upwards by 9.75% to $14.13. The market value of their outstanding shares is at $474.1 million. The company's, Q4 earnings came out yesterday. </li>
<li>Baiya International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIYA#NASDAQ">BIYA</a>) stock rose 9.54% to $7.0. The market value of their outstanding shares is at $87.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) stock declined by 28.8% to $2.92 during Friday's regular session. The company's market cap stands at $12.2 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) stock decreased by 24.52% to $0.44. The company's market cap stands at $13.7 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares decreased by 20.79% to $0.22. The company's market cap stands at $43.4 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) stock fell 20.28% to $1.73. The company's market cap stands at $23.5 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares declined by 17.31% to $0.43. The market value of their outstanding shares is at $5.4 million. </li>
<li>VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) stock declined by 17.05% to $4.28. The market value of their outstanding shares is at $48.2 million. The company's, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BIYA

CAPT

GTEC

HKPD

KSCP

LNZA

ONEG

SKYH

UGRO

VTSI

12 Industrials Stocks Moving In Friday's Intraday Session

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Friday.
Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply during Friday's session following a fourth-quarter EPS and <a href="https://www.benzinga.com/quote/AGX/earnings">revenue beat</a>.
Argan reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $1.15 per share. The company reported quarterly sales of $232.474 million which beat the analyst consensus estimate of $197.500 million.
Argan shares jumped 29.6% to $149.39 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) gained 16.7% to $1.7050 after the company reported better-than-expected quarterly sales results.</li>
<li>Abacus Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NYSE">ABL</a>) rose 15.8% to $8.28 following strong quarterly sales.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) shares surged 14.7% to $1.95 following strong quarterly earnings</li>
<li>W. R. Berkley Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) gained 14.2% to $75.70 after Mitsui Sumitomo Insurance announced that it is planning to acquire a 15% stake in the company.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) shares rose 13% to $41.54 as the company posted better-than-expected fourth-quarter results after Thursday's closing bell.</li>
<li>CureVac N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVAC#NASDAQ">CVAC</a>) gained 10.7% to $3.10 after the company announced it received a positive validity decision from the European Patent Office in its litigation against BioNTech SE.</li>
<li>Ascentage Pharma Group Internat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>) gained 9.3% to $22.07.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) rose 9.3% to $39.73.</li>
<li>Aeva Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NASDAQ">AEVA</a>) rose 8% to $6.89.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) climbed 7.8% to $13.85.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/25/03/44534992/how-to-earn-500-a-month-from-pvh-stock-ahead-of-q4-earnings"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44534992/how-to-earn-500-a-month-from-pvh-stock-ahead-of-q4-earnings">How To Earn $500 A Month From PVH Stock Ahead Of Q4 Earnings</a></li>
</ul>
Photo: Shutterstock

Intraday Update

AAPG

AEVA

BRZE

CVAC

KULR

ZLAB

Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday

Lake Street analyst Robert Brown upgrades Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) from Hold to Buy.

Upgrades

Analyst Ratings

Lake Street Upgrades Argan to Buy

Argan shares are trading higher following a Q4 EPS and revenue beat.

<h3>Gainers</h3>
<ul>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) stock rose 17.1% to $0.5 during Friday's pre-market session. The company's market cap stands at $16.3 million. </li>
<li>Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) stock moved upwards by 15.85% to $133.5. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Elong Power Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELPW#NASDAQ">ELPW</a>) shares rose 15.23% to $0.68. The market value of their outstanding shares is at $34.0 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares rose 15.06% to $1.68. The company's market cap stands at $401.9 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock increased by 11.99% to $0.75. The market value of their outstanding shares is at $11.1 million. </li>
<li>Skycorp Solar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PN#NASDAQ">PN</a>) shares rose 9.83% to $3.35. The market value of their outstanding shares is at $90.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) stock fell 18.1% to $0.24 during Friday's pre-market session. The market value of their outstanding shares is at $4.4 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares decreased by 16.27% to $0.09. The market value of their outstanding shares is at $12.7 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) shares fell 11.53% to $1.92. The market value of their outstanding shares is at $26.1 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares decreased by 8.41% to $0.25. The company's market cap stands at $50.1 million. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock fell 5.57% to $0.65. The market value of their outstanding shares is at $14.4 million. </li>
<li>VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) shares fell 5.52% to $4.88. The market value of their outstanding shares is at $54.9 million. As per the press release, Q4 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGLC

ELPW

SFHG

12 Industrials Stocks Moving In Friday's Pre-Market Session

Shares of Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong FY26 <a href="https://in.benzinga.com/news/earnings/25/03/44525443/braze-shares-soar-after-better-than-expected-q4-results-fy26-guidance-above-estimates">adjusted EPS guidance</a>.
Braze reported quarterly earnings of 12 cents per share, which beat the analyst consensus estimate of five cents. Quarterly revenue came in at $160.4 million, beating the $155.72 million consensus estimate.
Braze shares jumped 11.6% to $40.96 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Portage Biotech Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) gained 108% to $9.84 in pre-market trading after the company reported new data for PORT-7 at the 2025 European Lung Cancer Congress.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) rose 49.7% to $0.2724 in pre-market trading after gaining around 13% on Thursday.</li>
<li>Sensei Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) gained 25.4% to $0.5550 in pre-market trading after the company released its preliminary dose expansion data for Solnerstotug in PD-(L)1 resistant tumors.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) rose 22.1% to $0.6348 in pre-market trading after the company announced initial dosing in fourth cohort of Phase 1 clinical trial with TTX-MC138.</li>
<li>Prelude Therapeutics Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) gained 18% to $0.8042 in pre-market trading after gaining over 6% on Thursday.</li>
<li>KULR Technology Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KULR#NYSE">KULR</a>) rose 16.4% to $1.70 in pre-market trading after the company reported better-than-expected fourth-quarter sales results.</li>
<li>Sharps Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) surged 14.7% to $0.1752 in pre-market trading after dipping over 10% on Thursday.</li>
<li>Argan, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) gained 13.7% to $131.00 in pre-market after the company reported fourth-quarter financial results and beat its EPS and revenue estimates.</li>
<li>Alta Equipment Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) gained 13.3% to $5.60 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Direct Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares fell 36.1% to $0.8509 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) fell 29.7% to $1.73 in pre-market trading after the company announced a proposed public offering of common stock and warrants.</li>
<li>Mercer International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>) declined 23.2% to $5.00 in pre-market trading.</li>
<li>Dermata Therapeutics, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRMA#NASDAQ">DRMA</a>) shares dipped 21.1% to $1.12 in pre-market trading. Dermata Therapeutics announced exercise of warrants for $6.2 million in gross proceeds priced at-the-market under Nasdaq rules.</li>
<li>LogicMark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) dipped 20.5% to $0.0404 in pre-market trading after tumbling 45% on Thursday.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares tumbled 17.3% to $0.2104 in pre-market trading after falling 5% on Thursday.</li>
<li>Pineapple Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#NYSE">PAPL</a>) fell 16.7% to $0.2750 in pre-market trading after jumping 20% on Thursday.</li>
<li>Ascent Solar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) fell 16.7% to $1.49 in today's pre-market trading. Ascent Solar Technologies received an order for Advanced Space PV Module Design Revision.</li>
<li>Oxford Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) fell 14.3% to $53.50 in pre-market trading after the company issued first-quarter and FY25 guidance below estimates.</li>
<li>Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares fell 11.4% to $302.40 in pre-market trading. Lululemon reported better-than-expected financial results for the fourth quarter. The company said it expects full-year 2025 revenue to be in the range of $11.15 billion to $11.3 billion versus estimates of $11.301 billion. The company sees full-year earnings in the range of $14.95 to $15.15 per share versus estimates of $15.30 per share</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/25/03/44513063/jim-cramer-stryker-is-a-good-company-likes-this-utilities-stock"> </a>
<ul>
<li><a href="https://www.benzinga.com/25/03/44513063/jim-cramer-stryker-is-a-good-company-likes-this-utilities-stock">Jim Cramer: Stryker Is A &#8216;Good&#8217; Company, Says He Likes This Utilities Stock</a></li>
</ul>
Photo: Shutterstock

ALTG

ASTI

DRCT

DRMA

LGMK

LULU

MERC

PAPL

PRLD

PRTG

PTIX

RNAZ

SNSE

STSS

XTIA

Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) stock moved upwards by 37.2% to $0.9 during Thursday's after-market session. The market value of their outstanding shares is at $13.4 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares moved upwards by 16.44% to $1.7. The company's market cap stands at $406.7 million. The company's, Q4 earnings came out today. </li>
<li>Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) shares moved upwards by 14.46% to $131.9. The company's market cap stands at $1.7 billion. The company's, Q4 earnings came out today. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares increased by 8.94% to $0.95. The company's market cap stands at $7.1 million. </li>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) stock moved upwards by 7.93% to $0.8. The market value of their outstanding shares is at $121.6 million. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) stock rose 6.38% to $4.5. The market value of their outstanding shares is at $95.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) shares decreased by 9.4% to $4.68 during Thursday's after-market session. The market value of their outstanding shares is at $52.6 million. As per the press release, Q4 earnings came out today. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares fell 9.2% to $0.27. The company's market cap stands at $4.8 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares decreased by 7.63% to $0.75. The market value of their outstanding shares is at $3.1 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) shares declined by 7.06% to $0.33. The market value of their outstanding shares is at $47.6 million. As per the press release, Q4 earnings came out today. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares decreased by 6.22% to $1.51. The market value of their outstanding shares is at $111.3 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 6.14% to $0.26. The market value of their outstanding shares is at $51.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CSLR

HUHU

NRGV

SCWO

SGLY

12 Industrials Stocks Moving In Thursday's After-Market Session

Argan shares are trading higher after the company reported Q4 financial results and beat its EPS and revenue estimates.

Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) reported quarterly earnings of $2.22 per share which beat the analyst consensus estimate of $1.15 by 93.04 percent. This is a 149.44 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $232.474 million which beat the analyst consensus estimate of $197.500 million by 17.71 percent. This is a 41.28 percent increase over sales of $164.554 million the same period last year.

Earnings Beats

Argan Q4 2024 GAAP EPS $2.22 Beats $1.15 Estimate, Sales $232.474M Beat $197.500M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Tsakos Energy Navigation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEN#NYSE">TEN</a>) is projected to report quarterly earnings at $0.40 per share on revenue of $154.43 million. 
• Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) is projected to report quarterly loss at $1.40 per share on revenue of $2.90 million. 
• PDS Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDSB#NASDAQ">PDSB</a>) is projected to report earnings for its fourth quarter. 
• FitLife Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTLF#NASDAQ">FTLF</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $14.95 million. 
• ADC Therapeutics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>) is expected to report quarterly loss at $0.35 per share on revenue of $19.67 million. 
• Telesat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSAT#NASDAQ">TSAT</a>) is expected to report earnings for its fourth quarter. 
• Acumen Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABOS#NASDAQ">ABOS</a>) is expected to report earnings for its fourth quarter. 
• Bitfarms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $53.82 million. 
• Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) is expected to report quarterly earnings at $0.19 per share on revenue of $608.95 million. 
• BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) is estimated to report quarterly earnings at $0.35 per share on revenue of $16.80 million. 
• Edap TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDAP#NASDAQ">EDAP</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $20.83 million. 
• TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) is likely to report quarterly loss at $0.35 per share on revenue of $8.24 million. 
• BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) is likely to report quarterly loss at $0.35 per share on revenue of $2.29 million. 
• Icecure Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) is expected to report quarterly loss at $0.07 per share on revenue of $1.07 million. 
• Jiayin Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) is likely to report earnings for its fourth quarter. 
• Ascentage Pharma Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPG#NASDAQ">AAPG</a>) is projected to report earnings for its fourth quarter. 
• Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) is estimated to report earnings for its fourth quarter. 
• Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONE#NASDAQ">UONE</a>) is projected to report earnings for its fourth quarter. 
• TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is likely to report quarterly earnings at $2.91 per share on revenue of $14.79 billion. 
• Sachem Cap (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SACH#AMEX">SACH</a>) is projected to report quarterly loss at $0.46 per share on revenue of $14.49 million. 
• Ermenegildo Zegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZGN#NYSE">ZGN</a>) is likely to report earnings for its Fiscal Year 2024. 
• Innate Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPHA#NASDAQ">IPHA</a>) is projected to report earnings for its Fiscal Year 2024. 
<h3>Companies Reporting After The Bell</h3>
• Dolphin Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $13.52 million. 
• Relmada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) is projected to report earnings for its fourth quarter. 
• Draganfly (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPRO#NASDAQ">DPRO</a>) is projected to report quarterly loss at $0.66 per share on revenue of $1.45 million. 
• Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) is projected to report quarterly loss at $0.09 per share on revenue of $3.85 million. 
• SeaStar Medical Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) is likely to report earnings for its fourth quarter. 
• INmune Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) is projected to report earnings for its fourth quarter. 
• TMC Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) is estimated to report earnings for its fourth quarter. 
• Strata Skin Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) is expected to report quarterly loss at $0.40 per share on revenue of $9.03 million. 
• IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) is expected to report quarterly loss at $0.08 per share on revenue of $13.00 million. 
• Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) is expected to report earnings for its fourth quarter. 
• TSS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) is expected to report earnings for its fourth quarter. 
• BioRestorative Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>) is likely to report quarterly loss at $0.27 per share on revenue of $475 thousand. 
• Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) is likely to report quarterly loss at $0.67 per share on revenue of $12.31 million. 
• Faraday Future (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFAI#NASDAQ">FFAI</a>) is expected to report earnings for its fourth quarter. 
• 374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) is likely to report quarterly loss at $0.02 per share on revenue of $100 thousand. 
• Lantern Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>) is estimated to report earnings for its fourth quarter. 
• Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) is projected to report quarterly loss at $0.95 per share on revenue of $920 thousand. 
• Unusual Machines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) is likely to report earnings for its fourth quarter. 
• BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) is expected to report earnings for its fourth quarter. 
• Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) is projected to report quarterly loss at $0.51 per share on revenue of $1.19 million. 
• VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $8.09 million. 
• Forian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORA#NASDAQ">FORA</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $5.37 million. 
• Spero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRO#NASDAQ">SPRO</a>) is likely to report quarterly loss at $0.31 per share on revenue of $6.20 million. 
• Beachbody Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BODI#NYSE">BODI</a>) is likely to report quarterly loss at $1.52 per share on revenue of $81.71 million. 
• Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) is expected to report earnings for its fourth quarter. 
• Valhi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHI#NYSE">VHI</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $19.48 million. 
• Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $81.13 million. 
• Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) is projected to report quarterly loss at $0.05 per share on revenue of $12.80 million. 
• AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $679.95 million. 
• Oxford Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $383.94 million. 
• P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) is expected to report quarterly loss at $0.17 per share on revenue of $385.80 million. 
• Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) is likely to report quarterly loss at $0.34 per share on revenue of $375 thousand. 
• Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $212.05 million. 
• HireQuest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQI#NASDAQ">HQI</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $9.30 million. 
• Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) is expected to report quarterly earnings at $5.65 per share on revenue of $3.52 billion. 
• Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) is likely to report quarterly loss at $0.11 per share on revenue of $294 thousand. 
• KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $2.87 million. 
• Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) is expected to report earnings for its fourth quarter. 
• Sky Harbour Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKYH#NYSE">SKYH</a>) is expected to report quarterly loss at $0.06 per share on revenue of $4.15 million. 
• Better Choice Co (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#AMEX">BTTR</a>) is likely to report earnings for its fourth quarter. 
• Pulse Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLSE#NASDAQ">PLSE</a>) is likely to report earnings for its fourth quarter. 
• Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $155.25 million. 
• Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) is likely to report quarterly loss at $0.14 per share on revenue of $68.43 million. 
• Spectral AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDAI#NASDAQ">MDAI</a>) is expected to report quarterly loss at $0.14 per share on revenue of $6.83 million. 
• Barfresh Food Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRFH#NASDAQ">BRFH</a>) is expected to report quarterly loss at $0.01 per share on revenue of $4.17 million. 
• Abacus Global Management (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $30.18 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABOS

ADCT

BCAB

BITF

BKTI

BKYI

The Beachbody Company, Inc. Class A Common Stock

BODI

BRFH

BRTX

BTTR

BZAI

CLSD

CODX

DLPN

DPRO

EDAP

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

FORA

FTLF

GEVO

GOVX

ICCM

INMB

IPHA

IRIX

IZEA

JFIN

LTRN

LVLU

MDAI

NUTX

PDSB

PIII

PLSE

PSTV

RLMD

SACH

SDST

SPRO

SSKN

TLSI

TSAT

TSSI

UMAC

UONE

UONEK

WKSP

Earnings Scheduled For March 27, 2025

Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) will release its quarterly earnings report on Thursday, 2025-03-27. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Argan to report an earnings per share (EPS) of $1.11.
Investors in Argan are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.74, which was followed by a 1.14% drop in the share price the next day.
Here's a look at Argan's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.26</td>
<td>0.97</td>
<td>0.52</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2</td>
<td>1.31</td>
<td>0.58</td>
<td>0.89</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>26.0%</td>
<td>10.0%</td>
<td>21.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1743004897_0.png" alt="eps graph" />
<h3>Argan Share Price Analysis</h3>
Shares of Argan were trading at $127.14 as of March 25. Over the last 52-week period, shares are up 138.65%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/AGX/earnings">To track all earnings releases for Argan visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Argan

RETO

Shares of construction-related stocks are trading lower amid economic worries driven by tariffs and trade policies. Investors may be expecting a decline in investment, which may also be weighing on the industry.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$60.00</td>
<td>$37.6K</td>
<td>185</td>
<td>8.6K</td>
</tr>
<tr>
<td>RKLB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$7.00</td>
<td>$312.5K</td>
<td>16.7K</td>
<td>2.5K</td>
</tr>
<tr>
<td>ZIM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$25.00</td>
<td>$76.4K</td>
<td>383</td>
<td>1.3K</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$81.00</td>
<td>$95.1K</td>
<td>84</td>
<td>1.0K</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$100.00</td>
<td>$1.4 million</td>
<td>4.4K</td>
<td>408</td>
</tr>
<tr>
<td>GE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$155.00</td>
<td>$26.5K</td>
<td>679</td>
<td>250</td>
</tr>
<tr>
<td>HTZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.50</td>
<td>$31.5K</td>
<td>5.8K</td>
<td>250</td>
</tr>
<tr>
<td>UPWK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$15.00</td>
<td>$29.0K</td>
<td>1.8K</td>
<td>202</td>
</tr>
<tr>
<td>LMT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$465.00</td>
<td>$33.2K</td>
<td>716</td>
<td>104</td>
</tr>
<tr>
<td>AGX</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$130.00</td>
<td>$44.4K</td>
<td>98</td>
<td>40</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding DAL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), we observe a call option trade with bullish sentiment. It expires in 70 day(s) on May 16, 2025. Parties traded 228 contract(s) at a $60.00 strike. The total cost received by the writing party (or parties) was $37.6K, with a price of $165.0 per contract. There were 185 open contracts at this strike prior to today, and today 8603 contract(s) were bought and sold. 
• Regarding RKLB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), we observe a put option trade with bullish sentiment. It expires in 679 day(s) on January 15, 2027. Parties traded 2500 contract(s) at a $7.00 strike. The total cost received by the writing party (or parties) was $312.5K, with a price of $125.0 per contract. There were 16707 open contracts at this strike prior to today, and today 2500 contract(s) were bought and sold. 
• Regarding ZIM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>), we observe a call option sweep with bearish sentiment. It expires in 14 day(s) on March 21, 2025. Parties traded 1249 contract(s) at a $25.00 strike. This particular call needed to be split into 66 different trades to become filled. The total cost received by the writing party (or parties) was $76.4K, with a price of $61.0 per contract. There were 383 open contracts at this strike prior to today, and today 1373 contract(s) were bought and sold. 
• Regarding UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we observe a call option sweep with bearish sentiment. It expires in 35 day(s) on April 11, 2025. Parties traded 569 contract(s) at a $81.00 strike. This particular call needed to be split into 22 different trades to become filled. The total cost received by the writing party (or parties) was $95.1K, with a price of $166.0 per contract. There were 84 open contracts at this strike prior to today, and today 1038 contract(s) were bought and sold. 
• Regarding VRT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), we observe a put option sweep with bearish sentiment. It expires in 14 day(s) on March 21, 2025. Parties traded 750 contract(s) at a $100.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $1.4 million, with a price of $1990.0 per contract. There were 4410 open contracts at this strike prior to today, and today 408 contract(s) were bought and sold. 
• Regarding GE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), we observe a put option sweep with neutral sentiment. It expires in 196 day(s) on September 19, 2025. Parties traded 50 contract(s) at a $155.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $530.0 per contract. There were 679 open contracts at this strike prior to today, and today 250 contract(s) were bought and sold. 
• For HTZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>), we notice a call option sweep that happens to be bearish, expiring in 315 day(s) on January 16, 2026. This event was a transfer of 210 contract(s) at a $3.50 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.5K, with a price of $150.0 per contract. There were 5821 open contracts at this strike prior to today, and today 250 contract(s) were bought and sold. 
• Regarding UPWK (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>), we observe a put option sweep with bullish sentiment. It expires in 41 day(s) on April 17, 2025. Parties traded 200 contract(s) at a $15.00 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $29.0K, with a price of $145.0 per contract. There were 1885 open contracts at this strike prior to today, and today 202 contract(s) were bought and sold. 
• Regarding LMT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), we observe a call option trade with bullish sentiment. It expires in 14 day(s) on March 21, 2025. Parties traded 20 contract(s) at a $465.00 strike. The total cost received by the writing party (or parties) was $33.2K, with a price of $1660.0 per contract. There were 716 open contracts at this strike prior to today, and today 104 contract(s) were bought and sold. 
• Regarding AGX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>), we observe a put option trade with neutral sentiment. It expires in 14 day(s) on March 21, 2025. Parties traded 20 contract(s) at a $130.00 strike. The total cost received by the writing party (or parties) was $44.4K, with a price of $2220.0 per contract. There were 98 open contracts at this strike prior to today, and today 40 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

RKLB

UBER

UPWK

10 Industrials Stocks With Whale Alerts In Today's Session

Argan's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) short percent of float has risen 27.14% since its last report. The company recently reported that it has 780 thousand shares sold short, which is 6.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Argan Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738864819_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Argan has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Argan's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Argan's peer group average for short interest as a percentage of float is 5.41%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Argan?

Press Releases

Argan, Inc.'s Gemma Power Systems Executes EPC Contract for a 1.2 GW Power Project in Texas

Argan, Inc. Appoints Brian Orlandi as CEO of SMC Infrastructure Solutions

Argan, Inc. Relocates Corporate Headquarters to Arlington, Virginia

Argan, Inc. to Announce Fourth Quarter and Fiscal Year-End 2025 Results and Host Conference Call on Thursday, March 27, 2025

Argan, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

Argan, Inc.'s Gemma Power Systems Receives Notice to Proceed on EPC Contract for a 1.2 GW Power Project in Texas

Argan, Inc. Appoints Lisa Larroque Alexander to Board of Directors

Argan, Inc. Announces Increase to Share Repurchase Program, Declares Regular Quarterly Cash Dividend of $0.375 Per Common Share

Argan, Inc.'s Gemma Renewable Power Recognized With 2025 Nexus Award for Partner of the Year

Argan, Inc. Announces Leadership Succession at The Roberts Company

Arcosa

AECOM

Ameresco

APi Group

Bowman Consulting Group Ltd. - Common Stock

Bowman Consulting Group

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)

Comments

Argan

뉴스

파트너 / 기고자

벤징가 글로벌